Drug Week
Susan Hasty, Publisher
Table of Contents . . . February 22nd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Coagulation Therapy - International Normalized Ratio Accurate After Lupus Anticoagulant Therapy
Crohn Disease - Clarithromycin-Ethambutol Therapy Ineffective
AIDS And HIV Therapy - Intermittent Treatment Can Reduce Cost, Complications
AIDS And HIV Therapy - Prednisolone Doesn't Protect Against Allergic Reactions To Antivirals
AIDS And HIV Vaccine - Controversial Oral Vaccine Said To Induce Immune Response
Drug Delivery - Band 3 Cross-Linking Improves Drug Delivery Via Red Blood Cells
Mental Health - Study Identifies Opportunity For The Development Of Improved Antipsychotics
Anal Fissures - Cellegy, Ventiv Initiate Planning For Anogesic Launch
Clinical Trials - Research To Address Symptoms Of Early Parkinson Disease
Clinical Trials - Training Agreement Will Offer Free Online EDC Certification To Independent Clinical Monitors
Drug Delivery - Collaboration Will Focus On Innovative Technology
Drug Development - Alliance Aims to Develop Human Antibody Therapeutics
Drug Development - Company Announces Its First Personalized Medicine Candidates
Generics - Pharmaceutical Resources Receives Final Approval For Metformin HCl
Huntington Disease - Amarin Announces Positive Results Of Phase II Studies Of LAX-101
Inflammatory Bowel Disease - Incara Granted Deligoparin Sodium As Generic Name For OP2000
Malignant Mesothelioma - Survival Data For Ribonuclease Anticancer Drug Are Encouraging
Mental Health - Single Isomer Of Celexa Receives FDA Approvable Letter
Ophthalmology - Study Shows Promise For Dry Eye Syndrome
Pharmacy Practice - State Monitoring Programs Seen As Key To Tackling OxyContin Abuse
Policy - Vermont Working On Another Drug Pricing Plan
Regulatory Issues - FDA Drug Approvals Slightly Faster
Renal Transplantation - FDA Committee Rejects New Rapamune Regimen
Research - ChemBridge, ChemBridge Research Laboratories Announce Collaboration With Pfizer
Technology - AstraZeneca Selects Ariba Enterprise Sourcing
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
